New hope for thyroid eye disease: drug may beat steroids after emergency surgery
NCT ID NCT07594912
First seen May 20, 2026 · Last updated May 24, 2026 · Updated 1 time
Summary
This study tests a new drug called teprotumumab against standard steroid treatment in 60 adults with severe thyroid eye disease causing vision loss. All participants will first have emergency eye surgery, then receive either teprotumumab or steroids for 24 weeks. The goal is to see which treatment better improves eyesight and reduces complications.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OPTIC NEUROPATHY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Zhongshan Ophthalmic Center, Sun Yat-sen University
Guangzhou, Guangdong, 510000, China
Conditions
Explore the condition pages connected to this study.